Stay updated with breaking news from Mark Plavsic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Received FDA Agreement Under Special Protocol Assessment (SPA) for the CoMpass Phase 3 Clinical TrialPositive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with Suprachoroidal Administration Presented at AAO 2023Preliminary Data from Phase 1 Trial in...
Received FDA Agreement Under Special Protocol Assessment for the CoMpass Phase 3 Clinical Trial Positive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing...
J. Jill Hopkins, M.D., Appointed as Chief Medical Officer and President of Research & DevelopmentMark Plavsic, Ph.D., Appointed as Chief Technology OfficerBOSTON--(BUSINESS WIRE)--Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC)...
By Oyin Adedoyin Aura Biosciences has appointed Dr. Jill Hopkins as chief medical officer and president of research and development. Mark Plavsic has also...